A Study of YL202 in Patients With Advanced Solid Tumors
Status:
NOT_YET_RECRUITING
Trial end date:
2027-02-28
Target enrollment:
Participant gender:
Summary
This study is a multicenter, open-label, phase II study of YL202 in China to evaluate the efficacy, safety, and PK characteristics of YL202 in selected patients with advanced solid tumors.